Agilent Technologies, Inc. (A): Price and Financial Metrics


Agilent Technologies, Inc. (A)

Today's Latest Price: $114.57 USD

0.79 (-0.68%)

Updated Dec 2 4:02pm

Add A to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

A Stock Summary

  • With a market capitalization of $35,566,599,494, Agilent Technologies Inc has a greater market value than 93.8% of US stocks.
  • A's current price/earnings ratio is 51.47, which is higher than 81.6% of US stocks with positive earnings.
  • Price to trailing twelve month operating cash flow for A is currently 41.45, higher than 90% of US stocks with positive operating cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Agilent Technologies Inc are RMD, BAX, CMI, CSGP, and IDXX.
  • A's SEC filings can be seen here. And to visit Agilent Technologies Inc's official web site, go to www.agilent.com.

A Stock Price Chart Interactive Chart >

Price chart for A

A Price/Volume Stats

Current price $114.57 52-week high $118.96
Prev. close $115.36 52-week low $61.13
Day low $114.13 Volume 1,735,789
Day high $115.95 Avg. volume 1,873,311
50-day MA $106.56 Dividend yield 0.62%
200-day MA $91.09 Market Cap 35.32B

Agilent Technologies, Inc. (A) Company Bio


Agilent Technologies provides bio-analytical solutions and services to the life sciences, diagnostics and genomics, chemical analysis, communications, and electronics industries worldwide. The company was founded in 1999 and is based in Santa Clara, California.

A Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$114.57$39.98 -66%

We started the process of determining a valid price forecast for Agilent Technologies Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Agilent Technologies Inc ranked in the 25th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Agilent Technologies Inc, consider:

  • The company has produced more trailing twelve month cash flow than 74.94% of its sector Healthcare.
  • The business' balance sheet suggests that 6% of the company's capital is sourced from debt; this is greater than just 17.82% of the free cash flow producing stocks we're observing.
  • A's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 41.59% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-66%
1%-66%
2%-66%
3%-65%
4%-65%
5%-65%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as A, try ILMN, SNN, ABC, LGND, and RMD.


A Latest News Stream


Event/Time News Detail
Loading, please wait...

A Latest Social Stream


Loading social stream, please wait...

View Full A Social Stream

Latest A News From Around the Web

Below are the latest news stories about Agilent Technologies Inc that investors may wish to consider to help them evaluate A as an investment opportunity.

Immunohistochemistry Market To Witness Steady Growth With Danaher, Merck KGaA, Thermo Fisher Scientific, PerkinElmer, Abcam Plc, Agilent Technologies, Bio SB, Bio-Rad Laboratories, Cell Signalling Technology and F. Hoffmann-La Roche among others

A report by The Insight Partner's on the Immunohistochemistry Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the market

OpenPR | October 1, 2020

Global Pharmaceutical Packaging Market Report Covers Growing Strategies Used By Top Key Players || Agilent Technologies (U.S.), Amcor, Gerresheimer, Schott

The motive of this strategic research report entitled Global Pharmaceutical Packaging Market Which offers company accounts, industry investors, and industry members with consequential insights to enable them to make reliable strategic decisions regarding the opportunities in the global Pharmaceutical Packaging

OpenPR | September 30, 2020

Gel Permeation Chromatography Market: COVID-19 Business Continuity Plan | Evolving Opportunities with Agilent Technologies Inc. and Bio-Rad Laboratories Inc. | Technavio

LONDON--(BUSINESS WIRE)-- #GelPermeationChromatographyMarket--The Global Gel Permeation Chromatography Market will grow by $381.67 mn during 2020-2024

Business Wire | September 30, 2020

COVID-19 impact on Immunohistochemistry (IHC) Market worth USD 2.7 billion by 2025 | Leading Companies are F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (US) Danaher Corporation (US), PHC Holding Corporation (Japan), Biocare Medical,

According to the new market research report "Immunohistochemistry/IHC Market by Product (Antibodies, Reagents (Chromogenic Substrates), Kits), Application (Diagnostics (Cancer, Infectious), Research, Forensic), End User (Hospitals, Diagnostic Laboratories, Academic) - Global Forecast to 2025", published by MarketsandMarkets™, analyzes and studies the

OpenPR | September 29, 2020

Gene Editing Market Size, Regional Insights and Industry Dynamics By 2023 | By Top Leading Vendors Intellia Therapeutics, Qiagen, GE Healthcare Lonza, Cellectis, Dharmacon, AstraZeneca, Agilent Technologies.

The Business Research Company offers "Gene Editing Global Market Report 2020-30: COVID-19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it

OpenPR | September 29, 2020

Read More 'A' Stories Here

A Price Returns

1-mo 8.87%
3-mo 15.19%
6-mo 27.26%
1-year 44.26%
3-year 71.25%
5-year 192.10%
YTD 35.17%
2019 27.54%
2018 1.67%
2017 48.32%
2016 10.16%
2015 3.46%

A Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full A Dividend History

Continue Researching A

Want to see what other sources are saying about Agilent Technologies Inc's financials and stock price? Try the links below:

Agilent Technologies Inc (A) Stock Price | Nasdaq
Agilent Technologies Inc (A) Stock Quote, History and News - Yahoo Finance
Agilent Technologies Inc (A) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9535 seconds.